Intra-Cellular Therapies
ITCI
#1327
Rank
โ‚ฌ13.17 B
Marketcap
123,99ย โ‚ฌ
Share price
0.06%
Change (1 day)
99.25%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -1,49ย โ‚ฌ

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -1,57ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,65ย โ‚ฌ an increase over its 2021 EPS that were of -3,41ย โ‚ฌ.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,49ย โ‚ฌ-43.8%
2022-2,65ย โ‚ฌ-22.29%
2021-3,41ย โ‚ฌ8.02%
2020-3,16ย โ‚ฌ20.9%
2019-2,61ย โ‚ฌ-5.63%
2018-2,77ย โ‚ฌ33.96%
2017-2,07ย โ‚ฌ-21.19%
2016-2,62ย โ‚ฌ-7.56%
2015-2,84ย โ‚ฌ174.53%
2014-1,03ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,24ย โ‚ฌ-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-9,76ย โ‚ฌ 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,09ย โ‚ฌ 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA